… promising new drugs to crucial clinical trials, here are … FDA has approved belantamabmafodotin (Blenrep) in combination with bortezomib and … representing the first contemporary medicine to show an OS … The phase 3 MATTERHORN trial demonstrated that adding the …

… Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib … Myeloma) clinical trial programme will be … Department of Haematology and Medical Oncology, said: … refractory to available treatments. Many patients with …

… combination with bortezomib and dexamethasone (BVd) for the treatment of adults … -7 phase III trial.1 The trial demonstrated that patients … Department of Hematology and Medical Oncology, touched on Blenrep … is working closely with FDA to make Blenrep available …

… of these cancerous cells. The FDA awarded Blenrep accelerated approval in … combination with the Takeda Pharmaceutical multiple myeloma drug Velcade, and another one in … and Legend Biotech, were both approved as fifth-line treatments. Carvykti has …

… US Food and Drug Administration has approved British drugmaker GSK… . The FDA approved Blenrep in combination with bortezomib and dexamethasone … or stopped responding to treatment after at least two … from two late-stage trials. One study showed the …

… FDA approval of Blenrep (belantamab mafodotin-blmf) in combination with bortezomib … phase III DREAMM-7 trial, which showed Blenrep BVd … in earlier treatment lines. Phase III trials DREAMM-8 … including China, where the drug has received Breakthrough Therapy …

… Food and Drug Administration (FDA) approved the antibody-drug conjugate Blenrep … Velcade (bortezomib) and dexamethasone (a combination known as BVd) for the treatment … -7 phase 3 trial, which showed that … associate professor of medicine at Stanford University …

… as a combination treatment with Takeda’s Velcade (bortezomib) and the … the drug failed a confirmatory trial, GSK pulled the drug from … and efficient communication between doctors and eye care specialists … amp; Johnson and Legend Biotech’s BCMA CAR-T therapy …

… the US Food and Drug Administration (FDA) has approved its … -blmf) in combination with bortezomib and dexamethasone (BVd) for … Dr. Sagar Lonial, Chief Medical Officer at the Winship Cancer … s use in earlier treatment lines. Ongoing trials, including DREAMM-8 …

… combination with bortezomib and dexamethasone for the treatment of certain … the department of hematology and medical oncology at Emory University, … . In July, the FDA’s Oncologic Drugs Advisory Committee (ODAC) … DREAMM-7 and DREAMM-8 trials. “It’s really …